Study of Metoclopramide in Small Bowel Capsule Endoscopy
Completed · Phase 4 · Has a placebo group
Conditions studied: Pill Capsule Endoscopy Completion Rates
In brief
Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design. The outcomes to be assessed are capsule study completion rates, gastric transit time, small bowel transit time, and the effect of diabetes on pill capsule completion rates. The purpose of the study is to assess if metoclopramide given prior to pill capsule endoscopy has any effect on pill capsule completion rate, gastric transit time, small bowel transit time, and pill capsule completion rates in diabetes.
Key facts
- Study ID
- NCT01630109
- Run by
- Ascension Health
- People needed
- 5
- Starts
- 2012-12-01
- Expected to finish
- 2013-06-01
- Last updated by the study team
- 2014-02-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women over the age of 18 undergoing pill capsule endoscopy to investigate unexplained rectal bleeding, anemia, iron deficiency, abdominal pain, altered bowel habits, and/or weight loss.
You may not qualify if…
- Inability to sign consent for research participation
- Inability to swallow PillCam™, placebo, or metoclopramide capsule
- Known hypersensitivity/allergy to metoclopramide
- Active congestive heart failure or respiratory failure requiring ventilator assistance
- Presence of cardiac pacemaker or implanted electromedical device
- Known bowel obstruction/stricture/fistula or intrauterine pregnancy
- Known history of Whipple procedure (pancreaticoduodenectomy), Billroth II surgery (partial gastrectomy with gastrojejunostomy), or gastric bypass surgery due to risk of capsule retention in a blind intestinal limb necessitating surgical retrieval
- Known history of seizure disorder, renal failure requiring dialysis, or pheochromocytoma
- Lactating women
Where it is running
- Genesys Regional Medical Center — Grand Blanc, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.